Tag: Primary Health

Trade deal will increase health inequities

Press Release – Doctors for Healthy Trade The TPPA is riddled with provisions that will widen already unacceptable health disparities says Dr Erik Monasterio, a spokesperson for Doctors for Healthy Trade. An analysis of the impact of the Trans-Pacific Partnership Agreement on health equity …STATEMENT FOR IMMEDIATE RELEASE, TUESDAY 28 JUNE 2016 Trade deal will increase health inequities “The TPPA is riddled with provisions that will widen already unacceptable health disparities” says Dr Erik Monasterio, a spokesperson for Doctors for Healthy Trade. An analysis of the impact of the Trans-Pacific Partnership Agreement on health equity co-authored by Dr Monasterio...

Read More

TPP’s biologics data protection

Article – BusinessDesk April 27 (BusinessDesk) – The Trans-Pacific Partnership’s longer data protection for biologic pharmaceutical makers will push up the cost of the fastest growing primary health treatment in the country, the Medical Association says.TPP’s biologics data protection will push up health-care costs, Medical Association says By Paul McBeth April 27 (BusinessDesk) – The Trans-Pacific Partnership’s longer data protection for biologic pharmaceutical makers will push up the cost of the fastest growing primary health treatment in the country, the Medical Association says. Biologic drugs account for more than 40 percent of new pharmaceutical products being developed and proposals...

Read More

Plain packaging: why are we waiting?

Press Release – Smokefree Coalition The Smokefree Coalition, along with groups like the Cancer Society, has been advocating for plain packaging since the measure was adopted in Australia back in 2011. Similar legislation was introduced here in 2014 but has been back-burnered due to Government …Plain packaging: why are we waiting? Dr Prudence Stone, Executive Director, The Smokefree Coalition, 11 April 2016 The Smokefree Coalition, along with groups like the Cancer Society, has been advocating for plain packaging since the measure was adopted in Australia back in 2011. Similar legislation was introduced here in 2014 but has been ‘back-burnered’ due to Government fears that we’ll be caught up in expensive international arbitration like Australia has been. Back in February Prime Minister John Key indicated our legislation could soon be back on the cards, but since then we’ve heard exactly zip. We’ve signed the TPP in which tobacco companies are excluded from litigation against governments; the public seems ready and willing; and the evidence is in that plain packaging will help prevent a lot of suffering and death. So why are we still waiting? The move by Philip Morris International (PMI) to litigate against Australia has shown good returns. It may not have won, but the millions of dollars’ worth of red tape it takes to fight such a deathly rich international company has frightened many governments and slowed the...

Read More

Lives lost as funding indecision continues

Press Release – New Zealand Labour Party Annette King Deputy Leader Health Spokesperson 22 January 2016 Lives lost as funding indecision continuesAnnette King Deputy Leader Health Spokesperson 22 January 2016 Lives lost as funding indecision continues The longer the Government continues its hands-off approach to funding a ground-breaking melanoma treatment the more lives will be lost, Labour’s Health spokesperson Annette King says. “Keytruda was approved for use by Pharmac in September, but given a low funding priority. “That means terminally ill Kiwis who have been told by their oncologists they could benefit from a course of the drug are being forced to fundraise tens of thousands of dollars for treatment or go without. “Latest Ministry of Health figures show melanoma was the second most common cancer in both males and females in 2013, with 2366 new cases registered that year. There were 354 deaths from melanoma in 2012. “Based on that information an average 30 Kiwis die each month from melanoma, so funding Keytruda four months ago could have saved, or extended, the lives of up to 120 sufferers. “Keytruda has been credited with saving many lives in Australia, the UK and the US, where it is funded. “One patient who has contacted me sums it up like this: I am not the sort of person to ask for help to pay for the treatment as I was brought...

Read More

The TPP: Why rush in where angels fear to tread?

Press Release – Public Health Association The Public Health Association of New Zealand (PHA) is questioning the rush to sign the Trans Pacific Partnership (TPP) Agreement and says there remain too many unanswered questions; too much public unease; and a palpable lack of detailed analysis for us …The TPP: Why rush in where angels fear to tread? Public Health Association media release, 14 January 2016 The Public Health Association of New Zealand (PHA) is questioning the rush to sign the Trans Pacific Partnership (TPP) Agreement and says there remain too many unanswered questions; too much public unease; and a palpable lack of detailed analysis for us to be adding our signature so quickly. “We may be flattered to have been selected as the country where the TPP will be signed in February, but that shouldn’t distract us from the very real questions and concerns around this agreement,” says PHA Chief Executive Warren Lindberg. “Disquiet has been prominent in the news of late, coming from a number of fronts including copyright and education. This indicates that full analysis of just what this agreement will cost the various sectors has not been done. “There has also been very little legal or academic analysis or commentary. The document amounts to 6000 or more complex pages and has been public knowledge for far too short a time for proper analysis, so why we’re...

Read More